Fmr Llc ownership in NPCE / NeuroPace, Inc.

NeuroPace, Inc.

US ˙ NasdaqGM ˙ US6412881053

Security	NPCE / NeuroPace, Inc.
Institution	Fmr Llc
Latest Disclosed Ownership	468,081 shares
Ownership	1.78%

2024-02-09 - Fmr Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 468,081 shares of NeuroPace, Inc. (US:NPCE). This represents 1.78 percent ownership of the company. In their previous filing dated 2023-02-09 , Fmr Llc had reported owning 1,449,926 shares, indicating a decrease of -67.72 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2024-02-09	2024-02-09	13G/A	1,449,926	468,081	-67.72	1.78	-69.43
2023-02-09	2023-02-09	13G		1,449,926		5.82

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	NEUROPACE	COM	641288105	553,529	-71,418	-11.43	7,279	-24.57	0.0001
2026-02-17	2025-12-31	13F	NEUROPACE	COM	641288105	624,947	625	0.10	9,649	49.92	0.0005
2025-11-13	2025-09-30	13F	NEUROPACE	COM	641288105	624,322	-1,124	-0.18	6,437	-7.62	0.0003
2025-08-14	2025-06-30	13F	NEUROPACE	COM	641288105	625,446	375,541	150.27	6,967	126.86	0.0004
2025-05-12	2025-03-31	13F	NEUROPACE	COM	641288105	249,905	234	0.09	3,071	9.95	0.0002
2025-02-13	2024-12-31	13F	NEUROPACE	COM	641288105	249,671	261	0.10	2,794	60.70	0.0002
2024-11-13	2024-09-30	13F	NEUROPACE	COM	641288105	249,410	16	0.01	1,738	-7.80	0.0001
2024-08-13	2024-06-30	13F	NEUROPACE	COM	641288105	249,394	-53,409	-17.64	1,885	-52.83	0.0001
2024-05-13	2024-03-31	13F	NEUROPACE	COM	641288105	302,803	-165,278	-35.31	3,997	-17.18	0.0003
2024-02-13	2023-12-31	13F	NEUROPACE	COM	641288105	468,081	-238,164	-33.72	4,826	-29.78	0.0004
2023-11-13	2023-09-30	13F	NEUROPACE	COM	641288105	706,245	-517,418	-42.28	6,872	25.06	0.0006
2023-08-11	2023-06-30	13F	NEUROPACE	COM	641288105	1,223,663	-269,268	-18.04	5,494	-20.69	0.0005
2023-08-11	2023-03-31	13F/A-1	NEUROPACE	COM	641288105	1,492,931	43,005	2.97	6,927	220.69	0.0006
2023-05-11	2023-03-31	13F	NEUROPACE	COM	641288105	1,492,931	43,005		6,927		0.0006
2023-02-13	2022-12-31	13F	NEUROPACE	COM	641288105	1,449,926	0	0.00	2,160	-60.27	0.0002
2022-11-10	2022-09-30	13F	NEUROPACE	COM	641288105	1,449,926	30,975	2.18	5,437	-22.59	0.0006
2022-08-12	2022-06-30	13F	NEUROPACE	COM	641288105	1,418,951	11,645	0.83	7,024	-39.21	0.0007
2022-05-13	2022-03-31	13F	NEUROPACE	COM	641288105	1,407,306	341,269	32.01	11,554	7.52	0.0009
2022-02-14	2021-12-31	13F	NEUROPACE	COM	641288105	1,066,037	652	0.06	10,746	-36.36	0.0008
2022-02-14	2021-09-30	13F/A-1	NEUROPACE	COM	641288105	1,065,385	5,326	0.50	16,886	-33.04	0.0013
2021-11-15	2021-09-30	13F	NEUROPACE	COM	641288105	1,065,385	5,326		16,886		0.0003
2021-08-13	2021-06-30	13F	NEUROPACE	COM	641288105	1,060,059	1,060,059		25,219		0.0020

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.